bf/NYSE:PFE_icon.jpeg

NYSE:PFE

Pfizer

  • Stock

USD

Last Close

27.78

28/03 20:00

Market Cap

155.11B

Beta: 0.59

Volume Today

39.79M

Avg: 21.42M

PE Ratio

14.35

PFCF: 18.40

Dividend Yield

6.19%

Payout:87.54%

  • industry

    Drug Manufacturers / General
  • exchange

    New York Stock Exchange
  • website

    www.pfizer.com
  • ipo date

    Jan 17, 1944
  • full time employees

    83,000
  • currency

    USD

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small mol...Show More

Earnings

Earnings per Share (Estimate*)

0.511.522015-07-282017-08-012019-07-292021-07-282023-08-01

Revenue (Estimate*)

50B100B150B200B2015-07-282017-08-012019-07-292021-07-282023-08-01

*Estimate based on analyst consensus

founders

  • Christina Warren
  • Kyung Ae Lee
  • Thomas A Wynn

investments

Money RaisedFunding RoundLead InvestorAnnounced DateOrganization Name
$37.4MVenture Round - EvolveImmune Therapeutics16-11-2023EvolveImmune Therapeutics
€94.9MSeries C - AgomAb Therapeutics11-10-2023AgomAb Therapeutics
$25MCorporate Round - CellCentricYes11-07-2023CellCentric
$25MPost-IPO Equity - Caribou BiosciencesYes29-06-2023Caribou Biosciences
$106.5MSeries E - Vedanta Biosciences25-04-2023Vedanta Biosciences
$25MPost-IPO Equity - ORIC PharmaceuticalsYes21-12-2022ORIC Pharmaceuticals
$60MSeries C - Carrick TherapeuticsYes01-12-2022Carrick Therapeutics
$20MCorporate Round - CytoReasonYes20-09-2022CytoReason
€90.5MPost-IPO Equity - ValnevaYes20-06-2022Valneva
$65MSeries B - Dren Bio14-06-2022Dren Bio

acquisitions

PriceAcquiree NameAnnounced DateTransaction Name
$43BSeagen13-03-2023Seagen acquired by Pfizer
$5.4BGlobal Blood Therapeutics08-08-2022Global Blood Therapeutics acquired by Pfizer
$11.6BBiohaven Pharmaceutical10-05-2022Biohaven Pharmaceutical acquired by Pfizer
A$179MResApp Health15-04-2022ResApp Health acquired by Pfizer
$525MReViral07-04-2022ReViral acquired by Pfizer
$6.7MArena Pharmaceuticals13-12-2021Arena Pharmaceuticals acquired by Pfizer
$2.3BTrillium Therapeutics23-08-2021Trillium Therapeutics acquired by Pfizer
Amplyx Pharmaceuticals28-04-2021Amplyx Pharmaceuticals acquired by Pfizer
$11.4BArray BioPharma17-06-2019Array BioPharma acquired by Pfizer
$340MTherachon08-05-2019Therachon acquired by Pfizer

num employees

  • 10001+

funding rounds

Money RaisedAnnounced DateLead InvestorsTransaction NameNumber of Investors
$31B16-05-2023Post-IPO Debt - Pfizer

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.